Article
As activist investor ratchets up pressure, Mereo makes more cuts to extend cash runway into 2025
Rating:
0.0
Views:
86
Likes:
1
Library:
1
Mereo BioPharma, under pressure from an activist investor, has reduced its head count to stretch its cash runway out into the second quarter of 2025. | Mereo BioPharma, under pressure from an activist investor, has reduced its head count to stretch its cash runway out into the second quarter of 2025. The biotech disclosed the cuts in a rebuttal to Rubric Capital Management's “low-risk strategy” for unlocking the value of its assets while preserving cash.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value